
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Graves' disease is more common among women and in people younger than 40 years of age.
Clinical Pearl of the Day: Graves’ Disease
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism).
Insight:
Sources:






